Folder View

Guidance on how to use bisphosphonates and other bone modifying drugs in haematology and oncology patients.Key words:Oncology, Haematology, Myeloma, Bone, Bisphosphonates, Denosumab

This document is in place to ensure that patients receive and benefit from complementary therapies in an informed and appropriate way and to provide a robust framework to support practitioners to provide complementary therapies safely and appropriately.

General overview of CINV including guidance on the prescribing of antiemetic's for CINV.Keywords: Emesis, nausea, vomiting, chemotherapy, anti-emetics, SACT.

How to assess and manage Systemic Anti-Cancer therapy induced Diarrhoea, patient education and management. Keywords: Drug therapy, chemotherapy, digestive system, diseases, gastrointestinal diseases, intestinal diseases, diarrhoea, immunotherapy, SACT.

Standard operating procedure for Bone Marrow Aspiration and Trephine biopsy

Guidance for the management of patients receiving treatment via CADD pump

Guidelines on when it is appropriate to use GSCF in haematology and oncology patients undergoing chemotherapy or stem cell harvest.Granulocyte colony stimulating factor; GCSF; cytotoxic; chemotherapy; haematology; stem-cell.

Admission criteria for patients attending the HODA with operational guidance.

This guideline applies to patients presenting to RCHT with potential side effects from immunotherapy treatment for cancer. It defines the optimal management.Keywords: Oncology, Immunotherapy, Cancer.

How to assess and manage patients with suspected malignant spinal cord compression

This guideline applies to patients presenting to RCHT with potential bowel obstruction as a consequence of cancer. It defines the agreed optimal management.

This guideline applies to patients presenting to RCHT with hypercalcaemia (high serum calcium) secondary to malignancy. It defines the optimal management.

This guideline applies to patients presenting to RCHT with potential new intracranial malignancy. This means patients with new primary brain tumours and patients with involvement of the central nervous system by extracranial malignancy (metastatic or secondary deposits). The guideline defines optimal management within the Trust.Keywords: Oncology, Immunotherapy, Cancer.

This guideline applies to patients presenting to RCHT with suspected neutropenic sepsis in the setting of their treatment for non-haematological malignancy. The guideline defines the optimal acute management within the Trust and gives guidance for safe ongoing care, including managed discharge.

How to assess and manage patients with evidence of metastatic disease where the primary source is not obvious.

SOP covering management of patients receiving hydroxycarbamide via a nurse led telephone and virtual clinic.

The procedure for management of the 24 Hour Advice Line Telephone for patients receiving SACT.Keywords: Advice Line, Chemotherapy.

Booking window for review of SACT patients before their second cycle of treatment.

Document to outline the procedure to support safe practice of part bag infusions of Systemic Anti-Cancer Therapy (SACT).Keywords: SACT, Safety, SACT infusion alert tags.

This document outlines guidelines for the prevention and management of extravasation and the rapid treatment of SACT injuries. It provides a guideline to assist practitioners in the care of patients who may have experienced a SACT extravasation injury.

Guidance and education on the prevention and management of oral complications and oral mucositis in patients receiving SACT.Keywords: Mucositis, stomatitis, mouth care, oral health assessment, SACT.

This policy applies to all staff working in cancer services who are in possession of up-to-date SACT competencies as outlined by UKONS and may be eligible for the SACT incentive payment.Keywords: Incentive, SACT.

Guidelines for the management of hypersensitivity in adults to Systemic Anti-Cancer Therapy. How to identify and manage hypersensitivity reactions and guidance on re-challenging.

Recommendations for the prescribing and administration of mesna with ifosfamide and cyclophosphamide for adult cancer patients.Keywords: Mesna, cyclophosphamide, ifosfamide, cystitis.

Defines the local guideline for safe administration of intrathecal chemotherapy, in accordance with national guidelines.

Defines the policy for safe handling and administration of cytotoxic SACT for the treatment of cancer. Keywords: SACT, cytotoxic, immunotherapy, administration, capacity, spillage, waste, chemotherapy, information, teaching, education, chemotherapy consent, prescribing.